🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join Flavia Castelino, MD (Flavia Castelino, MD), and another expert faculty member online tomorrow, November 17 at 7 PM EST for a #CME web broadcast on SSc-ILD bit.ly/SSCILD2020 #Rheumatology #MedEd

Excited to welcome our newest fellows from MassGeneral Medicine and UR Medicine in July 2021!

Such fantastic news for all of us MassGeneral Medicine, our country and the world! So well deserved Rochelle Walensky, MD, MPH #mghproud To rebuild CDC, Biden picks Rochelle Walensky politi.co/2JSSdF1 via POLITICO

Yes! #scleroderma #ILD has a new FDA approved treatment- #Tocilizumab 🙌🏽 gene.com/media/press-re…

Interested in joining our #rheumatology clinical faculty MassGeneral Medicine? We are hiring! Additional details and application info below: healthecareers.com/acr/job/facult… #rheumtwitter

The @scleroderma national patient conference starts today! Looking forward to discussing #scleroderma 101 for those newly diagnosed & connecting with patients & families. Registration is still open- scleroderma.org/conference #sclerodermathrive

🌟Don't miss these exciting CTD-PAH live-virtual escape rooms! 👥Flavia Castelino, MD & Dr. Hill 📅Wed, Nov. 3, 3-4PM ✍️Register: bit.ly/3n3DvLk 👥Dr. McLaughlin & Dr. Steen 📅Tues, Nov. 16, 4-5PM ✍️Register: bit.ly/2Z76CFr #MedEd #FOAMed #rheumatology #pulmonology

We are excited to kick off #ACR21 with our American College of Rheumatology colleagues! Join our faculty and fellows at their presentations. Here’s our line up for tomorrow.

Interesting Post-hoc analysis data from the RESOLVE-1 study that will impact future trial design and clinical care of Diffuse Cutaneous #SSc #ACR21 👉MMF should become STANDARD OF CARE in yr 1 👉Clinical trials of skin disease must include background immunosuppressive therapy

Good morning #ACR21! It’s a beautiful morning here in Boston. We have a packed lineup of presentations. Connect with us 👇

An exciting time for #rheum treatments. A comprehensive list of new FDA approved drugs & new drug indications for #lupus #scleroderma #vasculitis #myositis #ACR21

Nice come from behind 🥈 MGH Rheumatology House of DMARDs! Congrats to the new champions, Gulls of Galveston. #ACRKnowledgeBowl #ACR21

Important hand & mouth exercises for our #scleroderma patients. Occupational therapy is key. (Courtesy of Dr. Poole) @scleroderma #ACR21

Congrats @kmdsilvaMD! We miss you MGH Rheumatology!

This #WomenInMedicine month, it is time to #InvestInHer. Individuals and institutions must commit to providing financial resources needed to recruit, retain, and support re-entry of women in #healthcare.

We are looking forward to connecting with friends and colleagues in person during #ACR22! Here’s the schedule of presentations Mass General MDs.

NEW 2022 Cancer Screening Recommendations for idiopathic inflammatory #myositis American College of Rheumatology plenary. Stratified by subtype, antibody status, clinical features. #RheumTwitter #ACR22

Results from RECITAL trial in #rheum #ILD. Cyclophosphamide and Rituximab had greatest improvement in FVC in #myositis and MCTD. No improvement in #scleroderma lung fn but improved skin score. #ACR22 plenary. Now published The Lancet Respiratory Medicine thelancet.com/journals/lanre…

Great to see you Deji!

In honor of world #scleroderma day, join Dr. York BU/BMC Rheumatology and I on a discussion of hand involvement with @scleroderma. RSVP: scleroderma.org/BostonCME